Advertisement

Indian drugmaker News

alt
The company had posted a net profit of Rs 492.3 crore during the same period of previous fiscal.
alt
The pharmaceutical arm of Chinese conglomerate Fosun plans to buy a majority stake in India`s Gland Pharma Ltd. for as much as $1.26 billion, in what is being touted as the biggest Indian acquisition by a Chinese company.  
alt
Cadila Pharmaceuticals is the latest Indian drugmaker to face U.S. regulatory rebuke, as the FDA intensifies its scrutiny of the generic drugmakers.






Loading...
english news
NEWS ON ONE CLICK